Medexprim winner of the “Next Scale-Up Award”
On November 16th, the 5th edition of the AI for Health Summit was held at Station F. This event, organized by AI for Health, brought together the French health and AI ecosystem. Medexprim is proud to have received the “Next Scale Up” award for its trajectory since 2020. Thank you to AI for for Health!
Medexprim featured in AI for Health interactive European database
AI for Health has released an innovative and real-time updated Startup database of the best startups challenging healthcare with data and AI. This mapping features easy-to-find information from the European startup ecosystem through personalized cards such as type of solution, technology used, pathology or field targeted, number of employees, and more. Medexprim is one of the startups selected […]
Interview of Romain Cazavan, DSIH Magazine
Romain Cazavan, CEO of Medexprim, spoke with Aïssa Khelifa for DSIH, the French professional magazine devoted to Health IT. The interview was published on December 1, 2020 (read the original French version here). AKH: Hello Romain, what was the origin of Medexprim? RCA: Medexprim is a spin-off from the CHU de Toulouse. Karine had observed within […]
Medexprim selected by EuroQuity for Access2EIC – Seal of Excellence e-Pitch session
Medexprim is proud to be the only French startup, as well as the only European Real-World Data and Real-World Evidence company, to have been selected by Euroquity for the Access2EIC – Seal of Excellence e-Pitch session held last November 24, as one of the « best eight European companies that have recently received a Seal of […]
European Commission’s Seal of Excellence
This summer, Medexprim received the European Commission’s Seal of Excellence for MIDAC (Medical Imaging Data Against Coronavirus), our project submitted to the EIC Accelerator COVID call. MIDAC’s goal was to constitute a centralized, collaborative and openly accessible Datalake of imaging exams and ancillary data with patients affected or not by Covid-19, and either release them […]